Jenny M. Down
384 Victoria Street
Sydney, NSW 2010, Australia
Sydney, NSW 2010, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
An oncolytic adenovirus targeting SLAMF7 demonstrates anti-myeloma efficacy.
Journal: Leukemia
Published: September 17, 2024
Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid Leukemia.
Journal: Molecular cancer therapeutics
Published: January 28, 2024
Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial.
Journal: The journal of pathology. Clinical research
Published: September 14, 2023
Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche.
Journal: Journal for immunotherapy of cancer
Published: February 17, 2021
Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: April 27, 2018
Low-dose methotrexate in myeloproliferative neoplasm models.
Journal: Haematologica
Published: May 28, 2017
Melphalan modifies the bone microenvironment by enhancing osteoclast formation.
Journal: Oncotarget
Published: January 05, 2017
Thyrostimulin Regulates Osteoblastic Bone Formation During Early Skeletal Development.
Journal: Endocrinology
Published: May 29, 2015
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche.
Journal: Nature communications
Published: May 26, 2015
Real-time intravital imaging establishes tumor-associated macrophages as the extraskeletal target of bisphosphonate action in cancer.
Journal: Cancer discovery
Published: October 15, 2014
Experience of propofol sedation in a UK ERCP practice: lessons for service provision.
Journal: Frontline gastroenterology
Published: June 30, 2014
Last Updated: 09/26/2026